SOX2 and malignant glioma: Given that SOX2 is predominantly expressed in embryonic and adult stems cells, including neural progenitor cells, and re-activates in cancers, including malignant gliomas, we hypothesized that the re-activation program of SOX2 may play an important role in the carcinogenesis and maintenance of GBM.